QUALITY RISK MANAGEMENT FOR SALBUTAMOL PRESSURIZED METERED DOSE INHALERS
The risks for the functional characteristics of Salbutamol pressurized metered dose inhaler (pMDI), such as the uniformity of delivered dose, the distribution of salbutamol particles at the stages of the Andersen impactor (apparatus D), and the respirable fraction, were studied and identified. It is...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2019-01-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/633 |
| _version_ | 1826569754841710592 |
|---|---|
| author | N. A. Lyapunov E. P. Bezuglaya V. A. Bovtenko Yu. M. Stolper V. N. Baumer E. Yu. Bryleva |
| author_facet | N. A. Lyapunov E. P. Bezuglaya V. A. Bovtenko Yu. M. Stolper V. N. Baumer E. Yu. Bryleva |
| author_sort | N. A. Lyapunov |
| collection | DOAJ |
| description | The risks for the functional characteristics of Salbutamol pressurized metered dose inhaler (pMDI), such as the uniformity of delivered dose, the distribution of salbutamol particles at the stages of the Andersen impactor (apparatus D), and the respirable fraction, were studied and identified. It is shown that these risks can be associated with the solubility of salbutamol sulfate (SS), the formulation of pMDI, the water content in the SS and ethanol, as well as the particle size distribution of SS. A relationship is shown between the particle size distribution of the SS, the rate of their sedimentation and the performance characteristics of the preparation. The properties of SS crystals are investigated and the possibility of enantiomers presence is shown. The risks associated with the production process, the materials of the primary packaging and the correctness of the quality control procedures are discussed. It is shown that the use of containers made of aluminum alloy EN AW-5052-0 without internal coating does not pose the risk of the release of elemental impurities into the preparation. Unjustified replacement of actuators may pose a risk to the performance characteristics of Salbutamol pMDI and in vitro equivalence as compared with the reference medicinal product. |
| first_indexed | 2024-04-10T01:40:21Z |
| format | Article |
| id | doaj.art-7da47581f05e475abfc83f07d84b003a |
| institution | Directory Open Access Journal |
| issn | 2305-2066 2658-5049 |
| language | Russian |
| last_indexed | 2025-03-14T11:44:22Z |
| publishDate | 2019-01-01 |
| publisher | LLC Center of Pharmaceutical Analytics (LLC «CPHA») |
| record_format | Article |
| series | Разработка и регистрация лекарственных средств |
| spelling | doaj.art-7da47581f05e475abfc83f07d84b003a2025-03-02T09:53:22ZrusLLC Center of Pharmaceutical Analytics (LLC «CPHA»)Разработка и регистрация лекарственных средств2305-20662658-50492019-01-01044961633QUALITY RISK MANAGEMENT FOR SALBUTAMOL PRESSURIZED METERED DOSE INHALERSN. A. Lyapunov0E. P. Bezuglaya1V. A. Bovtenko2Yu. M. Stolper3V. N. Baumer4E. Yu. Bryleva5State Scientific Institution «Institute for Single Crystals» of the National Academy of Sciences of UkraineState Scientific Institution «Institute for Single Crystals» of the National Academy of Sciences of UkraineState Scientific Institution «Institute for Single Crystals» of the National Academy of Sciences of UkraineState Scientific Institution «Institute for Single Crystals» of the National Academy of Sciences of UkraineState Scientific Institution «Institute for Single Crystals» of the National Academy of Sciences of UkraineState Scientific Institution «Institute for Single Crystals» of the National Academy of Sciences of UkraineThe risks for the functional characteristics of Salbutamol pressurized metered dose inhaler (pMDI), such as the uniformity of delivered dose, the distribution of salbutamol particles at the stages of the Andersen impactor (apparatus D), and the respirable fraction, were studied and identified. It is shown that these risks can be associated with the solubility of salbutamol sulfate (SS), the formulation of pMDI, the water content in the SS and ethanol, as well as the particle size distribution of SS. A relationship is shown between the particle size distribution of the SS, the rate of their sedimentation and the performance characteristics of the preparation. The properties of SS crystals are investigated and the possibility of enantiomers presence is shown. The risks associated with the production process, the materials of the primary packaging and the correctness of the quality control procedures are discussed. It is shown that the use of containers made of aluminum alloy EN AW-5052-0 without internal coating does not pose the risk of the release of elemental impurities into the preparation. Unjustified replacement of actuators may pose a risk to the performance characteristics of Salbutamol pMDI and in vitro equivalence as compared with the reference medicinal product.https://www.pharmjournal.ru/jour/article/view/633salbutamolpressurized metered dose inhalerperformance characteristicuniformity of delivered dosefine particle dosecritical quality attributerisk |
| spellingShingle | N. A. Lyapunov E. P. Bezuglaya V. A. Bovtenko Yu. M. Stolper V. N. Baumer E. Yu. Bryleva QUALITY RISK MANAGEMENT FOR SALBUTAMOL PRESSURIZED METERED DOSE INHALERS Разработка и регистрация лекарственных средств salbutamol pressurized metered dose inhaler performance characteristic uniformity of delivered dose fine particle dose critical quality attribute risk |
| title | QUALITY RISK MANAGEMENT FOR SALBUTAMOL PRESSURIZED METERED DOSE INHALERS |
| title_full | QUALITY RISK MANAGEMENT FOR SALBUTAMOL PRESSURIZED METERED DOSE INHALERS |
| title_fullStr | QUALITY RISK MANAGEMENT FOR SALBUTAMOL PRESSURIZED METERED DOSE INHALERS |
| title_full_unstemmed | QUALITY RISK MANAGEMENT FOR SALBUTAMOL PRESSURIZED METERED DOSE INHALERS |
| title_short | QUALITY RISK MANAGEMENT FOR SALBUTAMOL PRESSURIZED METERED DOSE INHALERS |
| title_sort | quality risk management for salbutamol pressurized metered dose inhalers |
| topic | salbutamol pressurized metered dose inhaler performance characteristic uniformity of delivered dose fine particle dose critical quality attribute risk |
| url | https://www.pharmjournal.ru/jour/article/view/633 |
| work_keys_str_mv | AT nalyapunov qualityriskmanagementforsalbutamolpressurizedmetereddoseinhalers AT epbezuglaya qualityriskmanagementforsalbutamolpressurizedmetereddoseinhalers AT vabovtenko qualityriskmanagementforsalbutamolpressurizedmetereddoseinhalers AT yumstolper qualityriskmanagementforsalbutamolpressurizedmetereddoseinhalers AT vnbaumer qualityriskmanagementforsalbutamolpressurizedmetereddoseinhalers AT eyubryleva qualityriskmanagementforsalbutamolpressurizedmetereddoseinhalers |